H
CVS icon

Hexavest’s CVS Health CVS Stock Holding History

Hexavest’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$12M Sell
141,673
-17,524
-11% -$1.47M 0.73% 40
2021
Q2 		$13.3M Buy
159,197
+6,510
+4% +$533K 0.66% 45
2021
Q1 		$11.5M Sell
152,687
-25,382
-14% -$1.85M 0.51% 59
2020
Q4 		$12.2M Sell
178,069
-98,908
-36% -$6.43M 0.46% 67
2020
Q3 		$16.2M Sell
276,977
-56,982
-17% -$3.55M 0.43% 72
2020
Q2 		$21.7M Sell
333,959
-163,631
-33% -$10.3M 0.5% 57
2020
Q1 		$29.5M Sell
497,590
-669,473
-57% -$44.7M 0.52% 61
2019
Q4 		$86.7M Sell
1,167,063
-48,480
-4% -$3.4M 1.06% 21
2019
Q3 		$76.7M Sell
1,215,543
-41,352
-3% -$2.45M 1.03% 22
2019
Q2 		$68.5M Sell
1,256,895
-106,027
-8% -$5.71M 0.9% 30
2019
Q1 		$73.5M Buy
1,362,922
+86,668
+7% +$5.35M 0.93% 32
2018
Q4 		$83.6M Buy
1,276,254
+23,946
+2% +$1.79M 1.22% 17
2018
Q3 		$98.6M Sell
1,252,308
-75,300
-6% -$5.38M 1.26% 16
2018
Q2 		$85.4M Buy
1,327,608
+6,575
+0.5% +$433K 1.1% 20
2018
Q1 		$82.2M Sell
1,321,033
-8,506
-0.6% -$610K 1.02% 25
2017
Q4 		$96.4M Buy
1,329,539
+204,618
+18% +$14.9M 1.1% 16
2017
Q3 		$91.5M Buy
1,124,921
+53,184
+5% +$4.21M 1.12% 18
2017
Q2 		$86.2M Sell
1,071,737
-53,007
-5% -$4.19M 1.12% 16
2017
Q1 		$88.3M Buy
1,124,744
+176,345
+19% +$14.1M 1.05% 18
2016
Q4 		$74.8M Buy
948,399
+390,112
+70% +$31.6M 1.03% 29
2016
Q3 		$49.7M Sell
558,287
-63,641
-10% -$6.01M 0.85% 35
2016
Q2 		$59.5M Buy
621,928
+245,677
+65% +$24.5M 0.9% 35
2016
Q1 		$39M Buy
376,251
+145,990
+63% +$14.2M 0.58% 53
2015
Q4 		$22.5M Sell
230,261
-1,229
-0.5% -$120K 0.36% 80
2015
Q3 		$22.3M Buy
231,490
+1,571
+0.7% +$165K 0.39% 76
2015
Q2 		$24.1M Sell
229,919
-5,967
-3% -$610K 0.4% 79
2015
Q1 		$24.3M Sell
235,886
-12,570
-5% -$1.27M 0.39% 73
2014
Q4 		$23.9M Buy
248,456
+2,242
+0.9% +$198K 0.36% 81
2014
Q3 		$19.6M Buy
246,214
+224
+0.1% +$17.7K 0.3% 93
2014
Q2 		$18.5M Buy
+245,990
New +$18.6M 0.28% 104

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hexavest's CVS Position: Q3 2021 in Review

Hexavest reduced its CVS Health (CVS) stake by 11% in Q3 2021, selling an estimated $1.47M and leaving 141,673 shares worth $12M. The position accounts for 0.73% of the portfolio, ranked #40.

Hexavest first reported a position in CVS in Q2 2014 and has held it in 30 quarters since. The position peaked at $98.6M in Q3 2018. 2,074 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Hexavest held 141,673 shares of CVS Health worth $12M as of Q3 2021.
  • Hexavest sold 17,524 CVS Health shares in Q3 2021, an estimated $1.47M.
  • CVS Health made up 0.73% of Hexavest's portfolio in Q3 2021, its #40 holding.
  • Hexavest first reported a position in CVS Health in Q2 2014 and has held it in 30 quarters since.
  • Hexavest's CVS Health position peaked at $98.6M in Q3 2018.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.